Events in the Series
World RNA Conference Calendar
RNA-based medicines have taken the spotlight in recent years and, following countless investments and collaborations, we have seen tremendous breakthroughs in development of RNA-based and RNA-targeting therapeutics and vaccines.
The World RNA Series presents a comprehensive portfolio of niche, industry-focused meetings, providing unrivaled knowledge-sharing and networking opportunities to help deliver safe and effective RNA and mRNA therapeutics and vaccines to patients faster.
View the World RNA Series conference calendar below. If you have any questions, get in touch at info@hansonwade.com.
mRNA PORTFOLIO
Advance Your mRNA Pipelines to Front-Line Treatments by Successfully Translating Proof-of-Concepts with Safety, Efficacy & Regulatory Approval
Ensuring Critical Regulatory Alignment for Analytical Characterization, Adopting Next-Generation Analytical Methods & Improving mRNA Characterization, Quality & Potency to Safeguard the Commercial Release of Your mRNA Therapeutics & Vaccines
Streamlining Purification, Yield & Scalability of Plasmid & Enzymatic DNA to Harmonize with Regulatory Expectations & Meet Increasing Global Demand for High Quality Therapeutics & Effective Vaccines
Enhance Speed, Purity, Flexibility & Scalability of Your Process Development & Manufacturing to Improve Functionality, Efficacy & Approval Rate of mRNA Drugs Across All Disease Indications
Supporting mRNA Purity, Stability & Raw Material Testing, Submission of Alternative Analytical Methods & Clarifying Documentation Requirements to Ensure Clinical Validation, Reduce Cost Risk, & Safeguard Regulatory Approval
Fast-Track Your mRNA-Based Therapeutics & Vaccines from Discovery to Commercialization by Ensuring Targeted Delivery, Durability & Tolerable Immunogenicity Across All Disease Indications
Optimising Analytical Technologies & Approaches to Characterisation, Standardisation, Quality & Potency to Permit Efficient Release & Commercial Approval of mRNA Medicines
Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into the Clinic & Beyond
RNA PORTFOLIO
Exposing the Latest Chemical & Pharmaceutical Advancements in RNAi Drug Discovery & Development Through Unlocking Novel Targets, Advancing Extra-Hepatic Delivery & Optimizing Chemical Modifications to Ensure Specific & Efficient Delivery to Target Tissues Across Organs & Diseases
Accelerate Circular, Self Amplifying & Transfer RNA into Safe & Effective Clinical Candidates with Therapeutic Potential Across All Disease by Overcoming Quality, Stability, Delivery & Large Scale Manufacturing Hurdles
Leverage AI, Machine Learning & Computational Modeling to Enhance & Automate Data Generation, Sequence Optimization & Delivery Chemistry for Scalable & Cost Effective RNA Therapeutic Discovery
Enhancing Specificity, Potency & Durability of RNA Editing Medicines by Harnessing Novel Delivery & Screening Platforms to Ensure Robust Clinical Validation in Oncology, CNS & Beyond
Realize the True Potential of RNA-Targeting Small Molecules through Optimizing Design & Technology of Improved Assays & Screens for Efficient Identification of Potent, Selection & Biologically Relevant RNA Targets
De-Risking Your RNA Therapeutic Safety & Tolerability with Optimized & Stable Non-Viral Formulations, Enhanced Conjugation Strategies & Improved Targeted Extrahepatic Delivery to Achieve Clinical Success
Revolutionize the Next Era of Cancer Immunotherapy Towards Clinical Success Through Harnessing Neoantigens & Developing Affordable Tailor-Made Individualized Vaccines
Improve Rational Design, Specificity & Selectivity of Small Molecules Targeting RNA to Enable Safe & Effective Drugs to Accelerate into the Clinic